US 10702528
Hepatitis B antiviral agents
granted A61KA61K31/505A61K31/506
Quick answer
US patent 10702528 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/5377, A61K31/5386